Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Salestools Logo

Salestools

#1 AI-agent til salgsteams og Go-to-Market-teams. Sælg mere, hurtigere, med mindre indsats.

Produkt

  • AI-salgsagenter
  • Intent-data
  • Teknologidata
  • Besøgssporing
  • Co-Pilot
  • Socialt salg

Løsninger

  • Kundeservice
  • E-handel
  • SaaS
  • Enterprise
  • Lille virksomhed

Ressourcer

  • Rapporten
  • Dokumentation
  • API-reference
  • Hjælpecenter
  • Blog
  • Case-studier
  • Webinarer

Virksomhed

  • Om os
  • Karriere
  • Presse
  • Kontakt
  • Partnere

Vores lokationer

  • New York, HQ
  • Bukarest, AI-forskningslaboratorium
  • Zug, Schweiz

© 2026 Salestools. Alle rettigheder forbeholdes.

Datavilkår & sikkerhedPrivatlivspolitikServicevilkårAcceptable Use
Alle systemer operationelle
Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Back to Reports
Fundraising

BNP Paribas

BNP Paribas Raises $80B in Public

16 Boulevard des Italiens, Paris 75009, FranceJanuary 1, 20242 min read
Employees
185000+

BNP Paribas Raises $80B in Public


BNP Paribas has successfully raised $80B in a Public at a $85B valuation led by Public.


Company Overview


BNP Paribas is a Banking company headquartered in 16 Boulevard des Italiens, Paris 75009, France, founded in 1848 with 185000+ employees.


French multinational bank


Fundraising Details


  • Amount Raised: $80B
  • Round Type: Public
  • Valuation: $85B
  • Date: 2024-01-01
  • Investors: Public

About BNP Paribas


French multinational bank The company is positioned in the Banking sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 16 Boulevard des Italiens, Paris 75009, France
  • Founded: 1848
  • Team Size: 185000+
  • Industry: Banking

What This Means


This funding round demonstrates strong investor confidence in BNP Paribas's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Banking sector continues to attract significant investment as companies innovate to meet evolving market demands. BNP Paribas's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $85B valuation marks an important milestone for BNP Paribas, positioning the company among notable players in the Banking industry.


Looking Ahead


With this new capital, BNP Paribas is well-positioned to execute on its growth strategy and continue building innovative solutions in the Banking space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about BNP Paribas, visit their headquarters at 16 Boulevard des Italiens, Paris 75009, France.

Company Info

Headquarters
16 Boulevard des Italiens, Paris 75009, France
Founded
1848
Team Size
185000+

Topics

Fundraising(2912)Public(771)BankingBNP Paribas

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free